InvestorsHub Logo
Followers 1
Posts 64
Boards Moderated 0
Alias Born 06/25/2013

Re: fcpgalltheway post# 11740

Monday, 04/21/2014 6:18:06 PM

Monday, April 21, 2014 6:18:06 PM

Post# of 13509
Good information fcpgalltheway.

Now it appears Wang is going to get both a higher top end growth and a fatter gross margin with the change in pricing policy.

Wang was hopping for this when he went national.
With a change in the Chinese policies of not capping medicine retail prices on medicines will now allow pharmaceutical companies to set prices. This will place First China in a better money making environment. With the ability of expanding dollar sales with existing customer base and the dropping of the additional sales dollars to the gross margin will just add to the attractiveness. This will be good for the future stock price of this company.

I do not know why the hold up in financials but, all I do know up until now the stock has not been ordered to stop trading and the big E has not been placed at the end of the stock symbol.

Marcum as of last week still has FCPG listed as a customer and they are still the auditor of record. Nothing materially has changed with this regard.
From the fact Marcum has not hastily presented any financials with corrections to follow may be the silver lining in this whole financial debacle.

When and I mean when the financials are posted I cannot imagine them not being audited. If they are submitted and are not audited then in my opinion that would be a total negative for this stock


Good investing to all and remember do your DD.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.